Leffa, Douglas T. http://orcid.org/0000-0002-4890-8451
Ferrari-Souza, João Pedro
Bellaver, Bruna
Tissot, Cécile http://orcid.org/0000-0003-2711-3833
Ferreira, Pamela C. L.
Brum, Wagner S.
Caye, Arthur
Lord, Jodie
Proitsi, Petroula http://orcid.org/0000-0002-2553-6974
Martins-Silva, Thais http://orcid.org/0000-0001-5049-2435
Tovo-Rodrigues, Luciana
Tudorascu, Dana L.
Villemagne, Victor L.
Cohen, Ann D.
Lopez, Oscar L. http://orcid.org/0000-0002-8546-8256
Klunk, William E.
Karikari, Thomas K. http://orcid.org/0000-0003-1422-4358
Rosa-Neto, Pedro http://orcid.org/0000-0001-9116-1376
Zimmer, Eduardo R.
Molina, Brooke S. G. http://orcid.org/0000-0001-7574-3755
Rohde, Luis Augusto http://orcid.org/0000-0002-4552-4188
Pascoal, Tharick A. http://orcid.org/0000-0001-9057-8014
,
Funding for this research was provided by:
Brain and Behavior Research Foundation (29486)
Ministry of Science, Technology and Innovation | Conselho Nacional de Desenvolvimento Científico e Tecnológico (166407/2020-8)
Article History
Received: 11 July 2022
Revised: 7 October 2022
Accepted: 1 November 2022
First Online: 8 December 2022
Competing interests
: LAR has received grant or research support from, served as a consultant to, and served on the speakers’ bureau of Aché, Bial, Medice, Novartis/Sandoz, Pfizer/Upjohn, and Shire/Takeda in the last three years. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by LAR have received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Novartis/Sandoz and Shire/Takeda. LAR has received authorship royalties from Oxford Press and ArtMed. AC has acted as a consultant for Knight Therapeutics in the last three years.